Larson Financial Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-33
Closed -$1K 969
2021
Q2
$1K Buy
+33
New +$1.84K ﹤0.01% 807

Other funds holding ORTX

Larson Financial Group's ORTX Position: Q3 2021 in Review

Larson Financial Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 33 shares — an estimated $1K sold.

Larson Financial Group first reported a position in ORTX in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • Larson Financial Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Larson Financial Group sold 33 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $1K.
  • Larson Financial Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • Larson Financial Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Larson Financial Group's 13F filing for Q3 2021, filed 4 Nov 2021.